GeneLink, Inc. (GNLKQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Mar 4, 2026, 4:00 PM EST
GeneLink Market Cap
GeneLink has a market cap or net worth of $10.6 thousand as of March 5, 2026. Its market cap has decreased by -86.67% in one year.
Market Cap
10.60K
Enterprise Value
n/a
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 17, 1999, GeneLink's market cap has decreased from 4.78M to 10.60K, a decrease of -99.78%. That is a compound annual growth rate of -20.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 10.60K | 3,900.38% |
| Dec 1, 2023 | 265.00 | - |
| Dec 22, 2022 | 265.00 | - |
| Dec 31, 2021 | 265.00 | -99.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scopus BioPharma | 16.83K |
| Regenicin | 15.35K |
| Q BioMed | 14.51K |
| Virpax Pharmaceuticals | 13.30K |
| ObsEva | 11.72K |
| Biostax | 10.71K |
| Trevena | 10.64K |
| Statera Biopharma | 7.26K |